Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging
- 31 May 2005
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 71 (5) , 357-361
- https://doi.org/10.1016/j.contraception.2004.11.005
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourseContraception, 2002
- Microbicides—evaluating multiple formulations of C31GContraception, 2002
- Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trialThe Lancet, 2002
- Distribution of topical medication in the human vagina as imaged by magnetic resonance imagingFertility and Sterility, 2001
- Distribution of a spermicide containing Nonoxynol-9 in the vaginal canal and the upper female reproductive tract.Human Reproduction, 2001
- Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfateAntiviral Research, 1999
- The microbicidal agent C31G inhibits Chlamydia trachomatis infectivity in vitroAntimicrobial Agents and Chemotherapy, 1997
- Assessment of the anti-microbial agent C31G as a spermicide: Comparison with nonoxynol-9Contraception, 1996
- C31G, a new agent for oral use with potent antimicrobial and antiadherence propertiesAntimicrobial Agents and Chemotherapy, 1988